369 related articles for article (PubMed ID: 2543913)
41. Identification and characterization of leukotriene D4 receptors in adult and fetal human lung.
Lewis MA; Mong S; Vessella RL; Crooke ST
Biochem Pharmacol; 1985 Dec; 34(24):4311-7. PubMed ID: 3000383
[TBL] [Abstract][Full Text] [Related]
42. Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma.
Rovati GE; Giovanazzi S; Mezzetti M; Nicosia S
Biochem Pharmacol; 1992 Oct; 44(7):1411-5. PubMed ID: 1329767
[TBL] [Abstract][Full Text] [Related]
43. Characterization of a leukotriene D4 receptor in guinea pig lung.
Pong SS; DeHaven RN
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7415-9. PubMed ID: 6324168
[TBL] [Abstract][Full Text] [Related]
44. Identification and transmembrane signaling of leukotriene D4 receptors in human mesangial cells.
Simonson MS; Mené P; Dubyak GR; Dunn MJ
Am J Physiol; 1988 Dec; 255(6 Pt 1):C771-80. PubMed ID: 2849305
[TBL] [Abstract][Full Text] [Related]
45. Subcellular distribution of leukotriene C4 binding units in cultured bovine aortic endothelial cells.
Chau LY; Hoover RL; Austen KF; Lewis RA
J Immunol; 1986 Sep; 137(6):1985-92. PubMed ID: 3745919
[TBL] [Abstract][Full Text] [Related]
46. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888.
Miyayasu K; Mak JC; Nishikawa M; Barnes PJ
Mol Pharmacol; 1993 Sep; 44(3):539-44. PubMed ID: 7690449
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the leukotriene D4 receptor in guinea-pig lung.
Mong S; Wu HL; Hogaboom GK; Clark MA; Crooke ST
Eur J Pharmacol; 1984 Jun; 102(1):1-11. PubMed ID: 6090152
[TBL] [Abstract][Full Text] [Related]
48. Guinea pig gall bladder contains a single peptide leukotriene receptor which resembles that present in human conducting airway smooth muscle.
Falcone RC; Krell RD
J Pharmacol Exp Ther; 1992 Sep; 262(3):1095-102. PubMed ID: 1326623
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms of leukotriene E4 partial agonist activity at leukotriene D4 receptors in differentiated U-937 cells.
Saussy DL; Sarau HM; Foley JJ; Mong S; Crooke ST
J Biol Chem; 1989 Nov; 264(33):19845-55. PubMed ID: 2555334
[TBL] [Abstract][Full Text] [Related]
50. In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist.
Snyder DW; Giles RE; Keith RA; Yee YK; Krell RD
J Pharmacol Exp Ther; 1987 Nov; 243(2):548-56. PubMed ID: 2824751
[TBL] [Abstract][Full Text] [Related]
51. The binding of [3H]leukotriene C4 to guinea-pig lung membranes. The lack of correlation of LTC4 functional activity with binding affinity.
Norman P; Abram TS; Kluender HC; Gardiner PJ; Cuthbert NJ
Eur J Pharmacol; 1987 Nov; 143(3):323-34. PubMed ID: 3691660
[TBL] [Abstract][Full Text] [Related]
52. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the leukotriene D4 receptor in hyperreactive rat lung.
Metters KM; Frey EA; Ford-Hutchinson AW
Eur J Pharmacol; 1991 Feb; 194(1):51-61. PubMed ID: 1647964
[TBL] [Abstract][Full Text] [Related]
54. Subclass-specific receptors for sulfidopeptide leukotrienes.
Austen KF; Lewis RA
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():329-32. PubMed ID: 3004142
[TBL] [Abstract][Full Text] [Related]
55. Analysis of the leukotriene D4 receptor in the granulation tissue of allergic inflammation in rats.
Hirasawa N; Hoshi T; Kudoh M; Mue S; Tsurufuji S; Watanabe M; Ohuchi K
Int Arch Allergy Immunol; 1992; 99(1):107-11. PubMed ID: 1336419
[TBL] [Abstract][Full Text] [Related]
56. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
Smith EF; Slivjak MJ; Eckardt RD; Newton JF
J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811
[TBL] [Abstract][Full Text] [Related]
57. Leukotriene B4 and leukotriene B5 have binding sites on lung membranes and cause contraction of bullfrog lung.
Andazola JJ; Underwood JA; Chiono M; Torres OA; Herman CA
J Pharmacol Exp Ther; 1992 Dec; 263(3):1111-7. PubMed ID: 1335056
[TBL] [Abstract][Full Text] [Related]
58. Pharmacological characterization of the cysteinyl-leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro.
Capra V; Bolla M; Belloni PA; Mezzetti M; Folco GC; Nicosia S; Rovati GE
Br J Pharmacol; 1998 Feb; 123(3):590-8. PubMed ID: 9504401
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.
Zwaagstra ME; Timmerman H; van de Stolpe AC; de Kanter FJ; Tamura M; Wada Y; Zhang MQ
J Med Chem; 1998 Apr; 41(9):1428-38. PubMed ID: 9554876
[TBL] [Abstract][Full Text] [Related]
60. Identification of leukotriene D4 receptor binding sites in guinea pig lung homogenates using [3H]leukotriene D4.
Cheng JB; Townley RG
Biochem Biophys Res Commun; 1984 Jan; 118(1):20-6. PubMed ID: 6320821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
